Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2014 December;56(4) > Panminerva Medica 2014 December;56(4):273-83

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

  MENOPAUSE IN 2014


Panminerva Medica 2014 December;56(4):273-83

language: English

Osteoporosis therapies in 2014

Litwic A. 1, Cooper C. 1, 2, Dennison E. 1

1 MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK;
2 IHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK


PDF  


Osteoporosis is a systemic disorder characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. It has a significant impact on public health through the increased morbidity, mortality, and economic costs associated with fractures. Despite the severe medical and socioeconomic consequences of fragility fractures, relatively few adults with fractures are evaluated and/or treated for osteoporosis. In this review, we summarize the existing treatment options and promising new therapies for the prevention and treatment of osteoporosis.

top of page

Publication History

Cite this article as

Corresponding author e-mail

emd@mrc.soton.ac.uk